NEW YORK (GenomeWeb News) – Protea Biosciences will use a new $1.7 million investment from the state of West Virginia to continue developing a new protein biomarker technology, which will be used to identify proteins in tissue and in other biological samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.